about
Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: The convolution continues.The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis.Can pharmacogenetics help rescue drugs withdrawn from the market?Personalizing Drug Selection Using Advanced Clinical Decision SupportGenotyping of the cytochrome P450 2D6 4469 C>T polymorphism using SimpleProbes.CYP2D6 gene test in psychiatric patients and healthy volunteers.
P2860
Q36522045-FB3FDE0C-F1CF-42A6-861A-488A9D1B60B0Q36544917-F808C6F4-C788-4D4C-B798-A7567824F54EQ36545135-9BEB9539-469C-41F0-838F-02B1941C12F7Q36596713-A93C5E10-09BF-43B0-9B9C-757C98F51048Q37412520-052E3038-5F3D-4C17-982E-4E848C63DC12Q51019253-AFD37B0C-4D66-4FA8-9F53-361FA74C5F1EQ51920384-73E1407B-5F7F-473B-9153-E27E7352BF82
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacogenetics-based new therapeutic concepts.
@ast
Pharmacogenetics-based new therapeutic concepts.
@en
type
label
Pharmacogenetics-based new therapeutic concepts.
@ast
Pharmacogenetics-based new therapeutic concepts.
@en
prefLabel
Pharmacogenetics-based new therapeutic concepts.
@ast
Pharmacogenetics-based new therapeutic concepts.
@en
P2093
P2860
P356
P1476
Pharmacogenetics-based new therapeutic concepts.
@en
P2093
Alfred G Hildebrandt
Christian Meisel
Gabriele Laschinski
Ingolf Cascorbi
Ivar Roots
Julia Kirchheiner
Jürgen Brockmöller
Mark Goldammer
Rolf Kaiser
Thomas Gerloff
P2860
P304
P356
10.1081/DMR-200033458
P407
P577
2004-10-01T00:00:00Z